93M1.DE 21.4 (-7.76%)
DE000A289V03Drug ManufacturersDrug Manufacturers - Specialty & Generic

MPH Health Care (93M1.DE) Competitor Comparison

We are evaluating the key criteria listed to compare MPH Health Care (93M1.DE) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - 93M1.DE ranking 0 / 54

These are the competitors of MPH Health Care in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Green Thumb Industries R9U2.F
57.58
2. ProPhase Labs PRPH
32.25
3. Kamada KMDA
26.61
4. Linc LNC
20.6
5. Organogenesis Holdings ORGO
20.5
6. Catalent CTLT
20.24
7. Alvotech ALVO
19.2
8. Zoetis ZTS
14.15
9. Cumberland Pharmaceuticals CPIX
12.81
10. Neoleukin Therapeutics NLTX
8.58
11. Pacira BioSciences PCRX
8.21
12. Avadel Pharmaceuticals AVDL
8.14
13. Alimera Sciences ALIM
7.82
14. Vifor Pharma G2AB.F
7.23
15. Curaleaf Holdings CURLF
6.97
16. Phibro Animal Health PAHC
6.92
17. PetIQ PETQ
6.43
18. Amphastar Pharmaceuticals AMPH
5.54
19. Teva Pharmaceutical Industries TEVA
5.2
20. Kolinpharma KIP.MI
4.88
21. Collegium Pharmaceutical COLL
4.51
22. Perrigo PRGO
4.12
23. Journey Medical DERM
3.9
24. Ayr Wellness 3KJB.F
3.71
25. Elanco Animal Health ELAN
3.62
26. Taro Pharmaceutical Industries TARO
3.55
27. Theratechnologies THTX
3.52
28. Ironwood Pharmaceuticals IRWD
3.34
29. Supernus Pharmaceuticals SUPN
3.33
30. ANI Pharmaceuticals ANIP
3.33
31. Bausch Health Companies BHC
3.29
32. Cronos Group CRON
2.99
33. Procaps Group PROC
2.59
34. Zynerba Pharmaceuticals ZYNE
2.47
35. Solid Biosciences SLDB
2.46
36. Jupiter Wellness JUPW
2.39
37. Embecta EMBC
2.38
38. Emergent BioSolutions EBS
2.26
39. Societal CDMO SCTL
2.21
40. Eagle Pharmaceuticals EGRX
2.19
41. SCYNEXIS SCYX
2.15
42. Relmada Therapeutics RLMD
2.06
43. Clever Leaves Holdings CLVR
1.87
44. Evolus EOLS
1.84
45. OptiNose OPTN
1.83
46. Tilray Brands TLRY
1.8
47. Alpha Teknova TKNO
1.78
48. Ascend Wellness Holdings AAWH
1.77
49. Biofrontera BFRI
1.74
50. Flora Growth FLGC
1.63
51. Universe Pharmaceuticals UPC
1.61
52. Regencell Bioscience Holdings RGC
1.48
53. Amneal Pharmaceuticals AMRX
1.41
54. Harrow Health HROW
0.62

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.